bepatient Revenue and Competitors
Estimated Revenue & Valuation
- bepatient's estimated annual revenue is currently $1.3M per year.
- bepatient's estimated revenue per employee is $87,000
Employee Data
- bepatient has 15 Employees.
- bepatient grew their employee count by -17% last year.
bepatient's People
| Name | Title | Email/Phone |
|---|
bepatient Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $114.2M | 630 | -5% | N/A | N/A |
#2 | $4.9M | 42 | -16% | N/A | N/A |
#3 | $60M | 326 | 0% | $102M | N/A |
#4 | $8.1M | 62 | 35% | N/A | N/A |
#5 | $6.8M | 52 | 6% | N/A | N/A |
#6 | $5.2M | 45 | -10% | N/A | N/A |
#7 | $24.6M | 154 | -1% | N/A | N/A |
#8 | $12.5M | 86 | 13% | N/A | N/A |
#9 | $2.9M | 29 | -29% | N/A | N/A |
#10 | $12.5M | 86 | -3% | N/A | N/A |
What Is bepatient?
bepatient is a French company headquartered in Paris, with an office in Sydney. We bring together a team of 30 people with complementary skills: health database management specialists, developers, designers, data managers, healthcare professionals and digital marketing experts. Since 2011, we have been developing a comprehensive and modular core platform, enabling to link the Patient to HCPs and generated value-added RWE data. Clinical Research - Virtual trials & RWE - Remote and patient-centric data capture solutions : ePRO, eCOA and eCRF - Smart integration of IoTs, connected medical devices, drug delivery systems, Point Of Care, imaging, scoring … - Pre-approval clinical trials to real-world post-market studies Digital Therapeutics - Prevention & Care Management - Fully customized PSP (Patient Support Programs), RPM (Remote Patient Monitoring), Corporate & Population Health programs - Large scope of care pathways (primary prevention, ambulatory, remote monitoring, care management,...) on multiple therapeutic areas
keywords:N/A
N/A
Total Funding
15
Number of Employees
$1.3M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
bepatient News
... Lynch pointed to the value of Garoppolo and the quarterback position, affirming that the team will be patient with his situation.
We'll be patient with that one. The 49ers traded up to draft Trey Lance with the third overall selection in 2021. Lance is expected to take...
The San Francisco 49ers are in no rush to make a decision on veteran quarterback Jimmy Garoppolo. At the start of the offseason, the Niners...
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.3M | 15 | -21% | N/A |
#2 | $1.8M | 15 | -25% | N/A |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $1.8M | 15 | -6% | N/A |
#5 | $1.8M | 15 | 7% | N/A |